GenTel BioSciences, Inc. Launches Thirteen APiX(TM) Human Tumor Profiling Kits to Support Cancer-Focused Protein Biomarker Research

MADISON, Wis.--(BUSINESS WIRE)--Gentel Biosciences, a leader in proteomics profiling tools, announces the availability of thirteen APiX™ Human Tumor Profiling Kits, robust tissue-lysate (reverse-phase) protein arrays and chromogenic-based detection reagents, suitable for the testing of putative protein biomarkers in over thirteen cancer subtypes.

Back to news